Sofosbuvir impurity N

• CAT Number: I013107
• CAS Number: 1394157-34-6
• Molecular Formula: C₂₀H₂₅FN₃O₉P
• Molecular Weight: 501.40
• Purity: ≥95%
• Target: HCV
• Solubility: DMSO
• IUPAC Name: methyl (2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate
• InChI: InChI=1S/C20H25FN3O9P/c1-12(17(27)30-3)23-34(29,33-13-7-5-4-6-8-13)31-11-14-16(26)20(2,21)18(32-14)24-10-9-15(25)22-19(24)28/h4-10,12,14,16,18,26H,11H2,1-3H3,(H,23,29)(H,22,25,28)/t12-,14+,16+,18+,20+,34?/m0/s1
• InChIKey: SASYBZIIPQSWBV-HJDNSYGMSA-N
• SMILES: C[C@@H](C(=O)OC)NP(=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3

Sofosbuvir Impurity N（Cat No.:I013107）is a byproduct or degradation product associated with the synthesis and stability of Sofosbuvir, a nucleotide analog prodrug used to treat hepatitis C virus (HCV) infections. This impurity is critical for analytical and pharmaceutical research, particularly in quality control and the development of robust manufacturing processes. Studying Sofosbuvir Impurity N helps ensure the safety, efficacy, and regulatory compliance of the final drug product. It also provides insights into the chemical stability and degradation pathways of Sofosbuvir, contributing to improved drug formulation and shelf-life optimization.